Effects of chocolate cyst fluid on endometrioma cell growth in culture

Fertility and Sterility

Volumn 70, Issue 5, 1998, Pages 827-830

  Badawy, Shawky Z A ^a   Cuenca, Violeta ^a   Kumar, Shubhra ^a   Holland, James ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Chocolate cyst fluid; Endometrioma; Transforming growth factor B1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CELLULAR IMMUNITY; CYST FLUID; ENDOMETRIUM CELL; ENDOMETRIUM TUMOR; HUMAN; HUMAN TISSUE; KILLER CELL; LYMPHOCYTE TRANSFORMATION; OVARY TUMOR; PRIORITY JOURNAL; TUMOR GROWTH;

CELL COUNT; CELL DIVISION; CELLS, CULTURED; CYST FLUID; ENDOMETRIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; OVARIAN CYSTS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032213872     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00303-3     Document Type: Article

References (20)

1. Sampson J.A. Perforating hemorrhagic (chocolate) cysts of the ovary. Arch Surg. 3:1921;245-323.
2. Brosens I.A., Puttemans P.J., Deprest J. The endoscopic localization of endometrial implants in the ovarian chocolate cyst. Fertil Steril. 61:1994;1034-1038.
3. DiZerega GS, Barber DL, Hodgen GD. Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression. Fertil Steril 653;33:649-53.
4. Oosterlynck D.J., Meuleman C., Wear M., Koninckx P.R. Transforming growth factor-B activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol. 83:1994;287-292.
5. Hammond M.G., Oh S.T., Anners J., Simly E.S., Halme J. The effect of growth factors on the proliferation of human endometrial cells in culture. Am J Obstet Gynecol. 168:1993;1131-1138.
6. Badawy S.Z., Holland J., Landas S., Frankel L., Cuenca V., Khan S. The role of estradiol, progesterone, and transforming growth factor on human endometrioma cell culture. Am J Reprod Immunol. 36:1996;58-63.
7. Sporn M.B., Roberts A.B. The transforming growth factor-B in peptide growth factors and their receptors. Sporn M.B., Roberts A.B. Handbook of Experimental Pharmacology. 95:1990;419-472 Springer-Verlag, New York.
8. Vercellini P., Vendola N., Cocciolone L., Columbo A., Rognoni M.T., Bolis G. Laparoscopic aspiration of ovarian endometriosis effect with postoperative gonadotropin releasing hormone agonist treatment. J Reprod Med. 37:1992;577-580.
9. Barbieri R.L., Ryan K.J. Medical therapy for endometriosis endocrine pharmacology . Semin Reprod Endocrinol. 3:1985;339-352.
10. McWilliam R., Leake R.E., Coutts J.R.T. Growth factors in human ovarian follicle fluid and growth factor receptors in granulosa luteal cells. Int J Biol Markers. 10:1995;216-220.
11. 1 in chronic hepatitis C. J Viral Hepatitis. 4:1997;29-35.
12. Dmowski W.P., Steele R.W., Baker G.F. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol. 141:1981;377-383.
13. Steele R.W., Dmowski W.P., Marmer D.J. Immunologic aspects of human endometriosis. Am J Reprod Immunol. 6:1984;33-36.
14. Oosterlynck D.J., Cormillic F.J., Waer M., Vandeputte M., Koninckx P.R. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril. 56:1991;45-51.
15. Oosterlynck D.J., Meuleman C., Waer M., Koninckx P.R., Vandeputte M. Immunosuppressive activity of peritoneal fluid in women with endometriosis. Obstet Gynecol. 82:1993;206-212.
16. Kanzaki H., Wang H.S., Kariya M., Mori T. Suppression of natural killer cell activity by sera from patients with endometriosis. Am J Obstet Gynecol. 167:1992;257-261.
17. Ishikawa N. Changes in natural killer (NK) activity and fertility during the establishment of experimental endometriosis in the rat. Acta Obstet Gynecol Jpn. 47:1995;457-464.
18. Koo G.C., Manyak C.L., Dasch J., Ellingsworth L., Shultz L.D. Suppressive effects of monocyte cells and transforming growth factor-beta on natural killer cell differentiation in autoimmune viable motheaten mutant mice. J Immunol. 147:1991;1194-1200.
19. Arteaga C.L., Hurd S.D., Winnier A.R., Johnson M.D., Fendly B.M., Forbes J.T. Anti-transforming growth factor-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression . J Clin Invest. 92:1993;2569-2576.
20. Williams R., Ross A., Chegini N., Stanwilliams R., Rossi A.M., Chegini N., et al. Effect of transforming growth factor beta on post operative adhesion formation and intact peritoneum. J Surg Res. 52:1992;65-70.